Sacubitril/Valsartan for Heart Failure: Exciting Times but Are Doctors Informed and Ready?

Prithwish Banerjee

Abstract


Sacubitril/Valsartan in now being prescribed by heart failure/cardiology teams across the United Kingdom following the publication of the NICE technology appraisal guidance but is everyone ready for it? This article discusses the practical aspects of what to do and not to do in relation to the drug  based on real world experience from our centre.

 


Keywords


Sacubitril valsartan, HFREF, heart failure

Full Text:

Banerjee-464-PDF HTML

References


McMurray JJ, Packer M, Desai AS, et al. PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med2014;371:993-1004. doi:10.1056/NEJMoa1409077. pmid:25176015

Ponikowski P, Voors AA, Anker SD, et al. on behalf of authors/task force members. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016 published online 20 May 2016. http://dx.doi.org/10.1093/eurheartj/ehw128

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C, 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure, Journal of the American College of Cardiology (2016), doi: 10.1016/j.jacc.2016.05.011.

Scottish Intercollegiate Guideline Network. Management of chronic heart failure. Edinburgh:SIGN:2016 (SIGN Guideline No 147), www.sign.ac.uk/assets/sign147.

National Institute for Health and Care Excellence. Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction. Apr 2016. https://www.nice.org.uk/guidance/ta388.

NICE approves innovative treatment for moderate to severe heart failure. BMJ 2016;353:i2402, doi: https://doi.org/10.1136/bmj.i2402.

Ali D, Riley F, Kirkland S, Hyland J, Banerjee P. Sacubitril/valsartan in chronic symptomatic heart failure with reduced ejection fraction: first clinical experience from a large uk tertiary centre. Heart Jun 2017, 103 (Suppl 5) A1; DOI: 10.1136/heartjnl-2017-311726.1

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v12i0.464

Copyright (c) 2018 Prithwish Banerjee

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.